home / stock / kalv / kalv short
Short Information | KalVista Pharmaceuticals Inc. (NASDAQ:KALV)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 714,094 |
Total Actual Volume | 7,425,222 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 35,705 |
Average Short Percentage | 14.08% |
Is there a KALV Short Squeeze or Breakout about to happen?
See the KALV Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-05-2024 | $11.55 | $11.79 | $12.07 | $11.45 | 267,568 | 49,734 | 18.59% |
07-03-2024 | $11.44 | $11.72 | $11.76 | $11.44 | 139,487 | 29,534 | 21.17% |
07-02-2024 | $11.91 | $11.51 | $12 | $11.48 | 249,948 | 44,808 | 17.93% |
07-01-2024 | $11.66 | $11.89 | $11.98 | $11.53 | 306,543 | 43,470 | 14.18% |
06-28-2024 | $12.2 | $11.78 | $12.2 | $11.42 | 2,314,196 | 41,394 | 1.79% |
06-27-2024 | $11.29 | $12.05 | $12.06 | $11.265 | 251,697 | 43,316 | 17.21% |
06-26-2024 | $11.56 | $11.31 | $11.89 | $10.845 | 635,654 | 96,348 | 15.16% |
06-25-2024 | $11.72 | $11.55 | $11.82 | $11.44 | 172,262 | 32,309 | 18.76% |
06-24-2024 | $11.77 | $11.72 | $11.97 | $11.61 | 167,750 | 31,062 | 18.52% |
06-21-2024 | $11.32 | $11.74 | $11.78 | $11.32 | 936,250 | 36,855 | 3.94% |
06-20-2024 | $11.33 | $11.21 | $11.35 | $11.07 | 161,857 | 22,590 | 13.96% |
06-18-2024 | $11.77 | $11.37 | $11.82 | $11.28 | 226,976 | 37,686 | 16.6% |
06-17-2024 | $11.99 | $11.82 | $12.1289 | $11.69 | 156,414 | 25,233 | 16.13% |
06-14-2024 | $12.21 | $12.07 | $12.21 | $11.97 | 229,591 | 12,647 | 5.51% |
06-13-2024 | $12.35 | $12.26 | $12.56 | $12.06 | 168,336 | 15,052 | 8.94% |
06-12-2024 | $12.47 | $12.35 | $12.66 | $12.17 | 302,133 | 36,242 | 12% |
06-11-2024 | $11.9 | $12.18 | $12.24 | $11.866 | 188,010 | 24,749 | 13.16% |
06-10-2024 | $11.61 | $12.04 | $12.14 | $11.59 | 203,078 | 39,085 | 19.25% |
06-07-2024 | $11.53 | $11.68 | $11.8 | $11.35 | 243,242 | 38,390 | 15.78% |
06-06-2024 | $12.08 | $11.85 | $12.08 | $11.76 | 104,230 | 13,590 | 13.04% |
News, Short Squeeze, Breakout and More Instantly...
KalVista Pharmaceuticals Inc. Company Name:
KALV Stock Symbol:
NASDAQ Market:
KalVista Pharmaceuticals Inc. Website:
KalVista Pharmaceuticals, Inc . (NASDAQ: KALV), today announced the initiation of the open-label KONFIDENT-KID clinical trial of sebetralstat, a novel, oral, plasma kallikrein inhibitor, in pediatric patients with hereditary angioedema (HAE). The trial will enroll approximately 24 children aged...
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced the submission of a New Drug Application (NDA) for U.S. Food and Drug Administration (FDA) review of sebetralstat, a novel investigational oral plasma kallikrein inhibitor for the on-demand treatment of hereditary angioedema (HAE) a...
– US subgroup in the phase 3 KONFIDENT trial demonstrates median time to treatment of 38 minutes and time to beginning of symptom relief 1.3 hours – – Despite growing use of long-term prophylaxis therapies in the US on-demand treatment prescription volumes stay stable...